1. Home
  2. GOODO vs MRK Comparison

GOODO vs MRK Comparison

Compare GOODO & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOODO
  • MRK
  • Stock Information
  • Founded
  • GOODO N/A
  • MRK 2000
  • Country
  • GOODO United States
  • MRK United States
  • Employees
  • GOODO 72
  • MRK N/A
  • Industry
  • GOODO Real Estate
  • MRK Biotechnology: Pharmaceutical Preparations
  • Sector
  • GOODO Real Estate
  • MRK Health Care
  • Exchange
  • GOODO Nasdaq
  • MRK Nasdaq
  • Market Cap
  • GOODO N/A
  • MRK 198.5B
  • IPO Year
  • GOODO N/A
  • MRK N/A
  • Fundamental
  • Price
  • GOODO $20.51
  • MRK $81.03
  • Analyst Decision
  • GOODO
  • MRK Buy
  • Analyst Count
  • GOODO 0
  • MRK 14
  • Target Price
  • GOODO N/A
  • MRK $108.54
  • AVG Volume (30 Days)
  • GOODO N/A
  • MRK 11.6M
  • Earning Date
  • GOODO N/A
  • MRK 10-30-2025
  • Dividend Yield
  • GOODO N/A
  • MRK 4.00%
  • EPS Growth
  • GOODO N/A
  • MRK 20.41
  • EPS
  • GOODO N/A
  • MRK 6.49
  • Revenue
  • GOODO N/A
  • MRK $63,616,000,000.00
  • Revenue This Year
  • GOODO N/A
  • MRK $1.91
  • Revenue Next Year
  • GOODO N/A
  • MRK $4.97
  • P/E Ratio
  • GOODO N/A
  • MRK $12.49
  • Revenue Growth
  • GOODO N/A
  • MRK 1.82
  • 52 Week Low
  • GOODO N/A
  • MRK $73.31
  • 52 Week High
  • GOODO N/A
  • MRK $119.38
  • Technical
  • Relative Strength Index (RSI)
  • GOODO 50.49
  • MRK 40.84
  • Support Level
  • GOODO $20.30
  • MRK $83.54
  • Resistance Level
  • GOODO $20.73
  • MRK $85.55
  • Average True Range (ATR)
  • GOODO 0.20
  • MRK 1.46
  • MACD
  • GOODO 0.00
  • MRK -0.40
  • Stochastic Oscillator
  • GOODO 43.06
  • MRK 2.25

About GOODO Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share

Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Share on Social Networks: